Psychedelic Innovation Fund

Psychedelic Innovation Fund is sponsored by LOHAS (fiscal sponsorship program of Legacy Global Programs). The Psychedelic Innovation Fund (PIF) advances the evidence-based use of psychedelic medicines and psychedelic-assisted therapies for mental health and neuroscience disorders.

Psychedelic Innovation Fund Clinical Trials & Research At PSI, we advance next-generation mental health and neuroscience treatments through evidence-based research evaluating the neuroplastogenic potential of psychedelic-assisted therapies, with the vision to transform care, improve quality of life, and expand human potential.

The Psychedelic Innovation Fund (PIF) supports this mission as the philanthropic engine powering PSI’s commitment to scientific advancement, education, equitable access, and a compassionate future for psychedelic medicine. The psychedelic treatment landscape is at a pivotal moment.

Clinical research is rapidly expanding across a wide range of mental health conditions—including depression, anxiety, PTSD, substance use disorders, end-of-life distress, and grief. Yet the path from promising research to widely available, insurance-covered care is long, complex, and resource-intensive. Significant philanthropic support and leadership are essential to bridge this gap.

PSI’s expert team of clinician-researchers in mental health, psychedelic-assisted therapy, clinical neuroscience, and healthcare strategy is committed to meeting this challenge. Please consider donating to the nonprofit Psychedelic Innovation Fund , a fiscal sponsorship program of Legacy Global Programs, a public 501(c)(3).

Tax-Deductible Giving Options: Charitable donations, foundation grants, donor-advised funds (DAFs) Recoverable grants (via SAFE note with 20% discount) View our Funding Flyer here. Our Psychedelic Innovation Fund Supporters We are deeply grateful to our philanthropic partners whose generosity fuels the Innovation Fund and the future of mental health and neuroscience.

The Pacific Neuroscience Institute Foundation The Congdon Family Foundation The Apfelbaum Family Foundation The Woolenberg Family Fund Thank you for investing in a future where rigorous psychedelic-assisted therapies are not only studied, but made safe, effective and accessible.

Accelerating Research & Education, Expanding Access The Psychedelic Innovation Fund directly supports PSI's core mission to: Advance Psychedelic Science We fund cutting-edge clinical trials and research exploring how psychedelics, as "neuroplastogens," can help optimize behavior, brain health, and quality of life.

This includes investigating medicines like psilocybin, LSD, 5-MeO-DMT, MDMA, and ibogaine to help achieve FDA approval and eventual integration into mainstream healthcare. We support eliminating financial barriers and ensuring that psychedelic-assisted therapies are available to a diverse and underserved populations, including BIPOC and LGBTQIA+ communities who are often overlooked in clinical research.

Support Education and Training We aim to train the next generation of psychedelic therapists and clinician-scientists while educating the public about psychedelic science and the therapeutic potential and responsible use of these medicines. Innovate in Creating Psychedelic-Based Care Models We are designing the mental health clinics of the future: affordable, sustainable, and scalable.

More Than a Donation, It's a Partnership When you contribute to the Psychedelic Innovation Fund, you become a partner in defining the next decade of psychedelic medicine. You are directly enabling research that is crucial for FDA approval and broader accessibility. This isn't about "miracle cures" or unproven claims; it's about rigorous science, structured care, and tangible progress.

Your support helps PSI continue its work as one of the few programs actively involved in developing multiple psychedelic treatments, positioning us to be among the first providers to offer these therapies upon FDA approval. We invite you to join us in advancing this vital field, contributing to a future where effective, safe, and accessible psychedelic-assisted therapies are available to all who need them.

Ready to contribute to the future of mental health? Donate to the Psychedelic Innovation Fund. Contact us to learn more about our research and initiatives.